Paper31320117
Advancing Drug Discovery via Artificial Intelligence.
Chan HCS and 4 others. Trends Pharmacol Sci, 2019. Cited by 305 papers, by iCite.
Cite this record
ConductScience Library. Advancing Drug Discovery via Artificial Intelligence. Papers, record 31320117. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/31320117
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Artificial Intelligence | Major topic |
| Drug Discovery | Major topic |
| Animals | |
| Humans | |
| Pharmaceutical Preparations | |
| Pharmacology | |
| Quantitative Structure-Activity Relationship | |
| Translational Research, Biomedical |
Source PubMed
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Erratum in | 31451243 | Advancing Drug Discovery via Artificial Intelligence. | https://conductscience.org/library/papers/31451243 |
Source PubMed
Cited by176
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 305 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42976131 | Rigorous nested cross-validation and external generalization-gap analysis of a machine-learning classifier for U-251 glioblastoma cytotoxicity. | PLoS One | 2026 | https://conductscience.org/library/papers/42976131 | PubMed |
| 42972226 | BENDER DB: a database of protein binding sites across neglected disease proteomes. | BMC Bioinformatics | 2026 | https://conductscience.org/library/papers/42972226 | PubMed |
| 42948713 | Application of computational methods in the drug discovery and development of Alzheimer's disease. | Acta Pharm Sin B | 2026 | https://conductscience.org/library/papers/42948713 | PubMed |
| 42852204 | AI-assisted systems pharmacology with experimental validation reveal multi-target anticancer mechanisms of Ganoderma lucidum extracts against lung cancer. | Mycology | 2026 | https://conductscience.org/library/papers/42852204 | PubMed |
| 42779713 | Machine Learning-Guided Discovery of Bacterial-Selective Membrane-Active Compounds Reveals Mechanistic Bias in Antibiotic Training Datasets. | bioRxiv | 2026 | https://conductscience.org/library/papers/42779713 | PubMed |
| 42778534 | Antibody-drug conjugate engineering: from design to efficacy and safety. | Signal Transduct Target Ther | 2026 | https://conductscience.org/library/papers/42778534 | PubMed |
| 42616280 | Applications of synthetic biology in biomedicine. | Mol Biomed | 2026 | https://conductscience.org/library/papers/42616280 | PubMed |
| 42611136 | A survey of transformer and LLM-based architectures, workflows, and systems in drug discovery. | J Comput Aided Mol Des | 2026 | https://conductscience.org/library/papers/42611136 | PubMed |
| 42602561 | dECM bioinks for 3D bioprinted tumor models: Advances, challenges, and drug screening. | iScience | 2026 | https://conductscience.org/library/papers/42602561 | PubMed |
| 42515751 | AI-Assisted Pharmaceutical Formulation Design: Comparative Development and Experimental Evaluation of Sustained-Release Lornoxicam Tablets. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/42515751 | PubMed |
| 42510714 | Ligand Design Using Unique Conformations to Preferentially Dock a Specific Site on Collagen-Bound MMP1. | Biology (Basel) | 2026 | https://conductscience.org/library/papers/42510714 | PubMed |
| 42327090 | Machine Learning-Guided Discovery of Bacterial-Selective Membrane-Active Compounds Reveals Mechanistic Bias in Antibiotic Training Datasets. | bioRxiv | 2026 | https://conductscience.org/library/papers/42327090 | PubMed |
| 42318231 | Parallelized contactless microfluidic dispenser with superhydrophobic nozzles for scalable combinatorial screening. | Biomicrofluidics | 2026 | https://conductscience.org/library/papers/42318231 | PubMed |
| 42253922 | Progress in Natural Products Target Discovery Technology. | MedComm (2020) | 2026 | https://conductscience.org/library/papers/42253922 | PubMed |
| 42182407 | Drug design using unique conformations to preferentially target a specific site on collagen-bound MMP1. | bioRxiv | 2026 | https://conductscience.org/library/papers/42182407 | PubMed |
| 42006621 | A comprehensive review of intelligent question-answering systems in traditional Chinese medicine based on LLMs. | J Pharm Anal | 2026 | https://conductscience.org/library/papers/42006621 | PubMed |
| 41909756 | AI-integrated microfluidics for drug screening: From single cell to organ-on-a-chip. | Acta Pharm Sin B | 2026 | https://conductscience.org/library/papers/41909756 | PubMed |
| 41744910 | Assessing the Efficacy of Artificial Intelligence Platforms in Answering Dental Caries Multiple-Choice Questions: A Comparative Study of ChatGPT and Google Gemini Language Models. | Dent J (Basel) | 2026 | https://conductscience.org/library/papers/41744910 | PubMed |
| 41685169 | Applications of AI/ML in accelerating the development of pulmonary drug delivery system. | Acta Pharm Sin B | 2026 | https://conductscience.org/library/papers/41685169 | PubMed |
| 41433248 | Mass Spectrometry Proteomics: A Key to Faster Drug Discovery. | J Med Chem | 2026 | https://conductscience.org/library/papers/41433248 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/31320117
GET https://conductscience.org/api/papers/v1/31320117/cited_by?page=2